Assyro AI

Orange Book product · Generic (ANDA)

IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE

IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

Generic (ANDA)ANDA 209235OTC AUROBINDO PHARMA

At a glance

Dec 01, 2017

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 01, 2017

    8 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

Strength

EQ 200MG FREE ACID AND POTASSIUM SALT;30MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

ANDA 209235

Product number

001

Marketing status

OTC

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.